📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

Tumor associated macrophages as key contributors and targets in current and future therapies for melanoma (2024)

First Author: Habib S

Attributed to: Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/1744666x.2024.2326626

PubMed Identifier: 38533720

Publication URI: http://europepmc.org/abstract/MED/38533720

Type: Journal Article/Review

Parent Publication: Expert Review of Clinical Immunology

Issue: 8

ISSN: 1744-666X